2021
DOI: 10.1016/j.jacep.2021.02.014
|View full text |Cite
|
Sign up to set email alerts
|

Pulsed Field Ablation of Paroxysmal Atrial Fibrillation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

14
249
1
5

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 271 publications
(332 citation statements)
references
References 34 publications
14
249
1
5
Order By: Relevance
“…A late update of the Farapulse studies revealed an 84.8% durability rate at repeat. Moreover, one should keep in mind that repeat procedures in volunteers (protocol-mandated) are more likely to provide higher durability rates compared to the durability rates observed in patients suffering from arrhythmia recurrence [24]. If the promise that electroporation results in tissue-selectivity and durability of isolation holds true, it seems obvious that that PFA will replace point-by-point RF ablation.…”
Section: Upcoming Technologies For Pulmonary Vein Isolation: the End Of The Close Protocol?mentioning
confidence: 99%
“…A late update of the Farapulse studies revealed an 84.8% durability rate at repeat. Moreover, one should keep in mind that repeat procedures in volunteers (protocol-mandated) are more likely to provide higher durability rates compared to the durability rates observed in patients suffering from arrhythmia recurrence [24]. If the promise that electroporation results in tissue-selectivity and durability of isolation holds true, it seems obvious that that PFA will replace point-by-point RF ablation.…”
Section: Upcoming Technologies For Pulmonary Vein Isolation: the End Of The Close Protocol?mentioning
confidence: 99%
“…In this study, we assessed acute PFA lesion formation (by the Farwave catheter, Farapulse Inc.) and level of PV isolation using ultrahigh‐density mapping (UHDx; with the multi‐electrode Orion™ mapping catheter and the Rhythmia™ 3D mapping system, Boston Scientific) combined with PFA catheter visualization in symptomatic AF patients undergoing PVI by PFA, including persistent AF patients receiving additional PFA lesions. This is the first description of a series of patients performed outside of the initial first‐in‐human work that has been published 4 …”
Section: Introductionmentioning
confidence: 99%
“…The lack of published data in this regard makes it necessary to make assumptions in terms of the applied waveforms or the irreversible electroporation electric field thresholds for cardiac tissue. Clinical trials are currently under development comparing RFA and PFA in terms of safety and effectiveness 30 .…”
Section: Introductionmentioning
confidence: 99%